Download PDF
Semin Respir Crit Care Med 2019; 40(01): 012-018
DOI: 10.1055/s-0039-1683891
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Deconstructing ARDS Variability: Platelet Count, an ARDS Intermediate Phenotype and Novel Mediator of Genetic Effects in ARDS

Paula Tejera
1   Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
,
David C. Christiani
1   Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
2   Massachusetts General Hospital (MGH), Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
06 May 2019 (online)

    Permissions and Reprints

Abstract

Genome-wide association studies (GWASs) in acute respiratory distress syndrome (ARDS) have been hampered by the heterogeneity of the clinical phenotypes and the large sample size requirement. As the limitations of these studies to uncover the complex genetic architecture of ARDS are evident, new approaches intended to reduce data complexity need to be applied. Intermediate phenotypes are mechanism-related manifestations of the disease, located closer to the genetic substrate than to disease phenotype, and therefore able to reflect more directly and more strongly the effect of causal genes. The dissection of complex phenotypes into less complex intermediate phenotypes is a valuable strategy to facilitate the discovery of those genetic variants whose effect is not strong enough to be detected as markers of disease in traditional GWASs. Genetic causal inference methodologies can be then applied to estimate the implication of the intermediate trait in the causal circuit between genes and disease. By following this strategy, platelet count, a relevant intermediate quantitative trait in ARDS, has been recently identified as a novel mediator in the genetic contribution to ARDS risk and mortality. The use of intermediate phenotypes and causal inference are emerging methodological and statistical strategies that can help to overcome the limitations of traditional GWASs in ARDS. Moreover, these approaches can provide evidence for the mechanisms linking genes to ARDS and help to prioritize therapeutic targets for the treatment of this devastating syndrome.

Keywords

ARDS - genetic epidemiology - intermediate phenotypes - platelet count - causal inference - biomarkers
 

  • References

  • 1 Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003; 349 (10) 996-998
    CrossrefPubMedGoogle Scholar
  • 2 Christie JD, Wurfel MM, Feng R. , et al; Trauma ALI SNP Consortium (TASC) investigators. Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. PLoS One 2012; 7 (01) e28268
    CrossrefPubMedGoogle Scholar
  • 3 Bime C, Pouladi N, Sammani S. , et al. Genome-wide association study in African Americans with acute respiratory distress syndrome identifies the selectin p ligand gene as a risk factor. Am J Respir Crit Care Med 2018; 197 (11) 1421-1432
    CrossrefPubMedGoogle Scholar
  • 4 Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006; 27 (04) 337-349
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Park JH, Wacholder S, Gail MH. , et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010; 42 (07) 570-575
    CrossrefPubMedGoogle Scholar
  • 6 Eichler EE, Flint J, Gibson G. , et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010; 11 (06) 446-450
    CrossrefPubMedGoogle Scholar
  • 7 Blanco-Gómez A, Castillo-Lluva S, Del Mar Sáez-Freire M. , et al. Missing heritability of complex diseases: enlightenment by genetic variants from intermediate phenotypes. BioEssays 2016; 38 (07) 664-673
    CrossrefPubMedGoogle Scholar
  • 8 Goldman D, Ducci F. Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. ScientificWorldJournal 2007; 7: 124-130
    CrossrefPubMedGoogle Scholar
  • 9 Li Y, Huang J, Amos CI. Genetic association analysis of complex diseases incorporating intermediate phenotype information. PLoS One 2012; 7 (10) e46612
    CrossrefPubMedGoogle Scholar
  • 10 Pingault JB, O'Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet 2018; 19 (09) 566-580
    CrossrefPubMedGoogle Scholar
  • 11 Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1334-1349
    CrossrefPubMedGoogle Scholar
  • 12 Bellingan GJ. The pulmonary physician in critical care * 6: the pathogenesis of ALI/ARDS. Thorax 2002; 57 (06) 540-546
    CrossrefPubMedGoogle Scholar
  • 13 Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122 (08) 2731-2740
    CrossrefPubMedGoogle Scholar
  • 14 Brun-Buisson C, Minelli C, Bertolini G. , et al; ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 2004; 30 (01) 51-61
    CrossrefPubMedGoogle Scholar
  • 15 Rubenfeld GD, Caldwell E, Peabody E. , et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353 (16) 1685-1693
    CrossrefPubMedGoogle Scholar
  • 16 Boyle AJ, Mac Sweeney R, McAuley DF. Pharmacological treatments in ARDS; a state-of-the-art update. BMC Med 2013; 11: 166
    CrossrefPubMedGoogle Scholar
  • 17 Standiford TJ, Ward PA. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl Res 2016; 167 (01) 183-191
    CrossrefPubMedGoogle Scholar
  • 18 Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 2018; 319 (07) 698-710
    CrossrefPubMedGoogle Scholar
  • 19 Hager DN. Recent advances in the management of the acute respiratory distress syndrome. Clin Chest Med 2015; 36 (03) 481-496
    PubMedGoogle Scholar
  • 20 Papazian L, Forel JM, Gacouin A. , et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363 (12) 1107-1116
    CrossrefPubMedGoogle Scholar
  • 21 Guérin C, Reignier J, Richard JC. , et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
    CrossrefPubMedGoogle Scholar
  • 22 Matthay MA, McAuley DF, Ware LB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med 2017; 5 (06) 524-534
    CrossrefPubMedGoogle Scholar
  • 23 Pelosi P, D'Onofrio D, Chiumello D. , et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 2003; 42: 48s-56s
    PubMedGoogle Scholar
  • 24 Calfee CS, Eisner MD, Ware LB. , et al; Acute Respiratory Distress Syndrome Network, National Heart, Lung, and Blood Institute. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007; 35 (10) 2243-2250
    CrossrefPubMedGoogle Scholar
  • 25 Tejera P, Meyer NJ, Chen F. , et al. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet 2012; 49 (11) 671-680
    CrossrefPubMedGoogle Scholar
  • 26 Calfee CS, Janz DR, Bernard GR. , et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 2015; 147 (06) 1539-1548
    CrossrefPubMedGoogle Scholar
  • 27 Reilly JP, Bellamy S, Shashaty MG. , et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc 2014; 11 (05) 728-736
    CrossrefPubMedGoogle Scholar
  • 28 Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA. ; NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014; 2 (08) 611-620
    CrossrefPubMedGoogle Scholar
  • 29 Meyer NJ, Calfee CS. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir Med 2017; 5 (06) 512-523
    CrossrefPubMedGoogle Scholar
  • 30 Jabaudon M, Blondonnet R, Audard J. , et al. Recent directions in personalised acute respiratory distress syndrome medicine. Anaesth Crit Care Pain Med 2018; 37 (03) 251-258
    PubMedGoogle Scholar
  • 31 Sinha P, Calfee CS. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine. Curr Opin Crit Care 2019; 25 (01) 12-20
    CrossrefPubMedGoogle Scholar
  • 32 Gong MN. Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment. Clin Chest Med 2006; 27 (04) 705-724 , abstract x
    CrossrefPubMedGoogle Scholar
  • 33 Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol 2009; 296 (05) L713 –L725
    CrossrefPubMedGoogle Scholar
  • 34 Flores C, Pino-Yanes MM, Casula M, Villar J. Genetics of acute lung injury: past, present and future. Minerva Anestesiol 2010; 76 (10) 860-864
    PubMedGoogle Scholar
  • 35 Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin Respir Crit Care Med 2013; 34 (04) 459-474
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Reilly JP, Christie JD, Meyer NJ. Fifty years of research in ARDS. Genomic contributions and opportunities. Am J Respir Crit Care Med 2017; 196 (09) 1113-1121
    CrossrefPubMedGoogle Scholar
  • 37 Barreiro LB, Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 2010; 11 (01) 17-30
    CrossrefPubMedGoogle Scholar
  • 38 Wang Z, Beach D, Su L, Zhai R, Christiani DC. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol 2008; 38 (06) 724-732
    CrossrefPubMedGoogle Scholar
  • 39 Juss J, Herre J, Begg M. , et al. Genome-wide transcription profiling in neutrophils in acute respiratory distress syndrome. Lancet 2015; 385 (Suppl 1): S55
    PubMedGoogle Scholar
  • 40 Kangelaris KN, Prakash A, Liu KD. , et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol 2015; 308 (11) L1102 –L1113
    CrossrefPubMedGoogle Scholar
  • 41 Grigoryev DN, Cheranova DI, Chaudhary S, Heruth DP, Zhang LQ, Ye SQ. Identification of new biomarkers for acute respiratory distress syndrome by expression-based genome-wide association study. BMC Pulm Med 2015; 15: 95
    CrossrefPubMedGoogle Scholar
  • 42 Simon BA, Easley RB, Grigoryev DN. , et al. Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291 (05) L851 –L861
    CrossrefPubMedGoogle Scholar
  • 43 Wan QQ, Wu D, Ye QF. Candidate genes as biomarkers in lipopolysaccharide-induced acute respiratory distress syndrome based on mRNA expression profile by next-generation RNA-seq analysis. BioMed Res Int 2018; 2018: 4384797
    PubMedGoogle Scholar
  • 44 Grigoryev DN, Ma SF, Irizarry RA, Ye SQ, Quackenbush J, Garcia JG. Orthologous gene-expression profiling in multi-species models: search for candidate genes. Genome Biol 2004; 5 (05) R34
    CrossrefPubMedGoogle Scholar
  • 45 Marshall RP, Webb S, Bellingan GJ. , et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 166 (05) 646-650
    CrossrefPubMedGoogle Scholar
  • 46 Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006; 34 (04) 1001-1006
    CrossrefPubMedGoogle Scholar
  • 47 Su L, Zhai R, Sheu CC. , et al. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med 2009; 35 (06) 1024-1030
    CrossrefPubMedGoogle Scholar
  • 48 Meyer NJ, Li M, Feng R. , et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011; 183 (10) 1344-1353
    CrossrefPubMedGoogle Scholar
  • 49 Lin Z, Pearson C, Chinchilli V. , et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000; 58 (03) 181-191
    CrossrefPubMedGoogle Scholar
  • 50 Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 2004; 125 (01) 203-211
    CrossrefPubMedGoogle Scholar
  • 51 O'Mahony DS, Glavan BJ, Holden TD. , et al. Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One 2012; 7 (12) e51104
    CrossrefPubMedGoogle Scholar
  • 52 Meyer NJ, Feng R, Li M. , et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med 2013; 187 (09) 950-959
    CrossrefPubMedGoogle Scholar
  • 53 Tejera P, Wang Z, Zhai R. , et al. Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome. Am J Respir Cell Mol Biol 2009; 41 (06) 696-704
    CrossrefPubMedGoogle Scholar
  • 54 Tejera P, O'Mahony DS, Owen CA. , et al. Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome. Am J Respir Cell Mol Biol 2014; 51 (02) 262-272
    PubMedGoogle Scholar
  • 55 Meyer NJ. Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome. Clin Chest Med 2014; 35 (04) 673-684
    CrossrefPubMedGoogle Scholar
  • 56 Flores C, Pino-Yanes MdelM, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008; 12 (05) R130
    CrossrefPubMedGoogle Scholar
  • 57 Acosta-Herrera M, Pino-Yanes M, Perez-Mendez L, Villar J, Flores C. Assessing the quality of studies supporting genetic susceptibility and outcomes of ARDS. Front Genet 2014; 5: 20
    PubMedGoogle Scholar
  • 58 Famous KR, Delucchi K, Ware LB. , et al; ARDS Network. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 2017; 195 (03) 331-338
    CrossrefPubMedGoogle Scholar
  • 59 Calfee CS, Delucchi KL, Sinha P. , et al; Irish Critical Care Trials Group. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 2018; 6 (09) 691-698
    CrossrefPubMedGoogle Scholar
  • 60 Jansen RC, Nap JP. Genetical genomics: the added value from segregation. Trends Genet 2001; 17 (07) 388-391
    CrossrefPubMedGoogle Scholar
  • 61 Westra HJ, Peters MJ, Esko T. , et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013; 45 (10) 1238-1243
    CrossrefPubMedGoogle Scholar
  • 62 Gibson G, Powell JE, Marigorta UM. Expression quantitative trait locus analysis for translational medicine. Genome Med 2015; 7 (01) 60
    CrossrefPubMedGoogle Scholar
  • 63 Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160 (04) 636-645
    CrossrefPubMedGoogle Scholar
  • 64 Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006; 7 (10) 818-827
    CrossrefPubMedGoogle Scholar
  • 65 Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues Clin Neurosci 2014; 16 (04) 525-537
    CrossrefPubMedGoogle Scholar
  • 66 Castellanos-Martín A, Castillo-Lluva S, Sáez-Freire Mdel M. , et al. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach. Genome Biol 2015; 16: 40
    CrossrefPubMedGoogle Scholar
  • 67 Nava-Gonzalez EJ, Gallegos-Cabriales EC, Leal-Berumen I, Bastarrachea RA. Mini-review: the contribution of intermediate phenotypes to gxe effects on disorders of body composition in the new OMICS era. Int J Environ Res Public Health 2017; 14 (09) E1079
    CrossrefPubMedGoogle Scholar
  • 68 Yadav H, Kor DJ. Platelets in the pathogenesis of acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2015; 309 (09) L915-L923
    CrossrefPubMedGoogle Scholar
  • 69 Zarbock A, Ley K. The role of platelets in acute lung injury (ALI). Front Biosci 2009; 14: 150-158
    PubMedGoogle Scholar
  • 70 Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med 1976; 61 (05) 585-589
    CrossrefPubMedGoogle Scholar
  • 71 Tomashefski Jr JF, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983; 112 (01) 112-126
    PubMedGoogle Scholar
  • 72 Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol 2009; 40 (02) 123-134
    CrossrefPubMedGoogle Scholar
  • 73 Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116 (12) 3211-3219
    CrossrefPubMedGoogle Scholar
  • 74 Weyrich AS, Zimmerman GA. Platelets in lung biology. Annu Rev Physiol 2013; 75: 569-591
    CrossrefPubMedGoogle Scholar
  • 75 Katz JN, Kolappa KP, Becker RC. Beyond thrombosis: the versatile platelet in critical illness. Chest 2011; 139 (03) 658-668
    CrossrefPubMedGoogle Scholar
  • 76 Hill RN, Shibel EM, Spragg RG, Moser KM. Adult respiratory distress syndrome: early predictors of mortality. Trans Am Soc Artif Intern Organs 1975; 21: 199-205
    PubMedGoogle Scholar
  • 77 Wang T, Liu Z, Wang Z. , et al. Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One 2014; 9 (04) e94124
    CrossrefPubMedGoogle Scholar
  • 78 Wei Y, Wang Z, Su L. , et al. Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk. Chest 2015; 147 (03) 607-617
    CrossrefPubMedGoogle Scholar
  • 79 Wei Y, Tejera P, Wang Z. , et al. A missense genetic variant in LRRC16A/CARMIL1 improves acute respiratory distress syndrome survival by attenuating platelet count decline. Am J Respir Crit Care Med 2017; 195 (10) 1353-1361
    CrossrefPubMedGoogle Scholar
  • 80 Reilly JP, Wang F, Jones TK. , et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med 2018; 44 (11) 1849-1858
    CrossrefPubMedGoogle Scholar
  • 81 Schafer DA, Jennings PB, Cooper JA. Dynamics of capping protein and actin assembly in vitro: uncapping barbed ends by polyphosphoinositides. J Cell Biol 1996; 135 (01) 169-179
    CrossrefPubMedGoogle Scholar
  • 82 Yang C, Pring M, Wear MA. , et al. Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell 2005; 9 (02) 209-221
    CrossrefPubMedGoogle Scholar
  • 83 Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001; 86 (01) 198-213
    Article in Thieme ConnectPubMedGoogle Scholar
  • 84 Hartwig JH, Barkalow K, Azim A, Italiano J. The elegant platelet: signals controlling actin assembly. Thromb Haemost 1999; 82 (02) 392-398
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Kor DJ, Carter RE, Park PK. , et al; US Critical Illness and Injury Trials Group: Lung Injury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: the LIPS-a randomized clinical trial. JAMA 2016; 315 (22) 2406-2414
    CrossrefPubMedGoogle Scholar